Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients
Axial involvement in psoriatic arthritis is quite common. There is no data on the use of tofacitinib, an oral Janus kinase inhibitor, in psoriatic arthritis patients with axial involvement, nor is there any data on its effect on active MRI sacroiliitis.The aim of the study was to assess the effect o...
Saved in:
| Main Authors: | E. E. Gubar, Yu. L. Korsakova, E. Yu. Loginova, A. V. Smirnov, S. I. Glukhova, T. V. Korotaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2021-05-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3015 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
7 year of sacroiliac radiographic progression in early psoriatic arthritis (preliminary results)
by: E. Yu. Loginova, et al.
Published: (2024-03-01) -
EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE
by: E. Yu. Loginova, et al.
Published: (2020-06-01) -
Impact of tofacitinib on patient-reported outcomes in patients with psoriatic arthritis. Data from the real clinical practice
by: L. D. Vorobyeva, et al.
Published: (2022-07-01) -
Specific features of axial involvement in psoriatic arthritis: data from real clinical practice
by: E. E. Gubar, et al.
Published: (2020-09-01) -
Involvement of the axial skeleton in psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2017-03-01)